SCHEMBL7987285

SCHEMBL7987285

COc1cc2nc(Nc3c(F)cccc3Cl)c3cncn3c2cc1OC

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980799 0.93 LCK (0.88) LCK
SCHEMBL7979982 0.93 LCK (0.78) LCK
SCHEMBL7982912 0.90 LCK (0.76) LCK
SCHEMBL7980264 0.89 LCK (0.75) LCK
SCHEMBL7970084 0.89 LCK (1.00) LCK
SCHEMBL7980258 0.87 LCK (0.69) LCK
SCHEMBL7981107 0.85 LCK (0.85) LCK
SCHEMBL7981267 0.85 LCK (0.79) LCK
SCHEMBL7987265 0.85 LCK (0.80) LCK
SCHEMBL7987266 0.85 LCK (0.80) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed